Abderrazzak Merzouki

2021

In 2021, Abderrazzak Merzouki earned a total compensation of $415.9K as Chief Operating Officer and Director at Sunshine Biopharma.

Compensation breakdown

Salary$109,927
Stock Awards$306,000
Total$415,927

Merzouki received $306K in stock awards, accounting for 74% of the total pay in 2021.

Merzouki also received $109.9K in salary.

Rankings

In 2021, Abderrazzak Merzouki's compensation ranked 11,098th out of 12,415 executives tracked by ExecPay. In other words, Merzouki earned more than 10.6% of executives.

ClassificationRankingPercentile
All
11,098
out of 12,415
11th
Division
Manufacturing
4,898
out of 5,505
11th
Major group
Chemicals And Allied Products
2,185
out of 2,375
8th
Industry group
Drugs
1,944
out of 2,096
7th
Industry
Pharmaceutical Preparations
1,440
out of 1,546
7th
Source: SEC filing on October 18, 2023.

Merzouki's colleagues

We found two more compensation records of executives who worked with Abderrazzak Merzouki at Sunshine Biopharma in 2021.

2021

Steve Slilaty

Sunshine Biopharma

Chief Executive Officer

2021

Camille Sebaaly

Sunshine Biopharma

Chief Financial Officer

News

You may also like